Pacer Advisors
MEDP icon

Pacer Advisors’s Medpace MEDP Stock Holding History

Pacer Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5M Sell
31,102
-15,279
-33% -$7.05M 0.04% 392
2026
Q1 		$22.3M Sell
46,381
-107,271
-70% -$54.9M 0.06% 290
2025
Q4 		$86.3M Buy
153,652
+42,362
+38% +$24M 0.22% 91
2025
Q3 		$57.2M Buy
111,290
+68,384
+159% +$29.9M 0.14% 156
2025
Q2 		$13.5M Buy
42,906
+20,561
+92% +$6.17M 0.03% 408
2025
Q1 		$6.81M Buy
22,345
+9,860
+79% +$3.32M 0.02% 564
2024
Q4 		$4.15M Buy
12,485
+3,616
+41% +$1.23M 0.01% 684
2024
Q3 		$2.96M Sell
8,869
-5,099
-37% -$1.94M 0.01% 810
2024
Q2 		$5.75M Buy
13,968
+9,022
+182% +$3.57M 0.01% 553
2024
Q1 		$2M Buy
4,946
+1,441
+41% +$507K ﹤0.01% 861
2023
Q4 		$1.07M Sell
3,505
-2,036
-37% -$550K ﹤0.01% 1107
2023
Q3 		$1.34M Sell
5,541
-857
-13% -$219K 0.01% 722
2023
Q2 		$1.54M Buy
6,398
+4,050
+172% +$841K 0.01% 835
2023
Q1 		$442K Sell
2,348
-2,486
-51% -$514K ﹤0.01% 1174
2022
Q4 		$1.03M Buy
4,834
+3,043
+170% +$608K 0.01% 816
2022
Q3 		$281K Buy
1,791
+1,402
+360% +$224K ﹤0.01% 1425
2022
Q2 		$58K Buy
389
+46
+13% +$6.66K ﹤0.01% 2092
2022
Q1 		$56K Sell
343
-4,509
-93% -$743K ﹤0.01% 2231
2021
Q4 		$1.06M Buy
4,852
+1,700
+54% +$356K 0.01% 1166
2021
Q3 		$597K Buy
3,152
+38
+1% +$6.93K 0.01% 1068
2021
Q2 		$550K Sell
3,114
-14
-0.4% -$2.42K 0.01% 1101
2021
Q1 		$513K Buy
3,128
+24
+0.8% +$3.67K 0.01% 1049
2020
Q4 		$432K Sell
3,104
-3,173
-51% -$400K 0.01% 1026
2020
Q3 		$701K Buy
+6,277
New +$726K 0.01% 863
2020
Q1 		– Sell
-7,534
Closed -$633K – 930
2019
Q4 		$633K Buy
+7,534
New +$583K 0.03% 712
2019
Q3 		– Sell
-10,566
Closed -$691K – 1191
2019
Q2 		$691K Sell
10,566
-648
-6% -$37.3K 0.02% 911
2019
Q1 		$661K Buy
+11,214
New +$670K 0.02% 528

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Pacer Advisors's MEDP Position: Q2 2026 in Review

Pacer Advisors reduced its Medpace (MEDP) stake by 33% in Q2 2026, selling an estimated $7.05M and leaving 31,102 shares worth $16.5M. The position accounts for 0.04% of the portfolio, ranked #392.

Pacer Advisors first reported a position in MEDP in Q1 2019 and has held it in 27 quarters since. The position peaked at $86.3M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Pacer Advisors held 31,102 shares of Medpace worth $16.5M as of Q2 2026.
  • Pacer Advisors sold 15,279 Medpace shares in Q2 2026, an estimated $7.05M.
  • Medpace made up 0.04% of Pacer Advisors's portfolio in Q2 2026, its #392 holding.
  • Pacer Advisors first reported a position in Medpace in Q1 2019 and has held it in 27 quarters since.
  • Pacer Advisors's Medpace position peaked at $86.3M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.